Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN for Attention deficit hyperactivity disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 21 adverse event reports in the FDA FAERS database where RIZATRIPTAN was used for Attention deficit hyperactivity disorder.

Most Reported Side Effects for RIZATRIPTAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,041 36.0% 2 88
Off label use 522 18.0% 0 27
Nausea 447 15.4% 1 26
Product use in unapproved indication 423 14.6% 0 20
Headache 335 11.6% 2 61
Hyperhidrosis 333 11.5% 0 19
Migraine 329 11.4% 0 79
Sedation 320 11.1% 1 1
Nightmare 314 10.8% 0 0
Drug intolerance 240 8.3% 0 41
Nephrolithiasis 240 8.3% 0 3
Drug ineffective for unapproved indication 228 7.9% 1 16
Hypersensitivity 216 7.5% 2 37
Swelling face 174 6.0% 2 11
Dysphonia 172 5.9% 0 14

Other Indications for RIZATRIPTAN

Migraine (1,365) Product used for unknown indication (762) Headache (129) Migraine with aura (26) Migraine without aura (18) Migraine prophylaxis (15) Hypoaesthesia (10) Suicidal ideation (9) Depression (8) Secondary progressive multiple sclerosis (8)

Other Drugs Used for Attention deficit hyperactivity disorder

METHYLPHENIDATE (5,500) LISDEXAMFETAMINE DIMESYLATE (3,936) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (3,423) RISPERIDONE (1,928) GUANFACINE (855) ATOMOXETINE (684) DEXTROAMPHETAMINE (484) VILOXAZINE (379) AMPHETAMINE ASPARTATE\AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (349) AMPHETAMINE (304)

Related Pages

RIZATRIPTAN Full Profile All Attention deficit hyperactivity disorder Drugs RIZATRIPTAN Demographics RIZATRIPTAN Timeline